Diclofenac and misoprostol vs CYP1A2 Substrates

Interacting Drugs
Diclofenac and misoprostol
vs
CYP1A2 Substrates
Security Level
Minor, Monitor Therapy
Mechanism
CYP1A2 Substrates: CYP1A2 Inhibitors (Moderate) may decrease the metabolism of CYP1A2 Substrates.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Diclofenac and misoprostol vs CYP1A2 Substrates